IPS Stock Analysis: Ipsos | PA
Consulting Services | PA, France | Market Cap: 1.490m EUR | 12M Return: 8.8% | FR0000073298 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 2.15M
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Ipsos SA is a Paris-headquartered, France-domiciled provider of survey-based research services operating globally across Europe, the Middle East, Africa, the Americas, and Asia-Pacific. The company delivers end-to-end work along the information production and analysis chain, covering data collection, processing and integration, analysis, delivery/presentation, and activation, and supports a broad portfolio of specialty practices including audience measurement, brand health tracking, customer experience, healthcare, innovation, public affairs, social intelligence analytics, and automotive and mobility development.
Ipsos also runs Ipsos.Digital, a do-it-yourself research platform, and offers online and mobile device-agnostic solutions, qualitative research, and advanced analytics built on artificial intelligence, machine learning, and behavioral science and neuroscience. Founded in 1975, the company is listed on Euronext Paris (ticker: IPS) and sits within the GICS Industrials sector under the Research & Consulting Services sub-industry. The market research industry has historically been highly fragmented, with Ipsos competing alongside other large multinational agencies; the sector has been shifting away from traditional survey-only methods toward digital, programmatic sampling, and AI-driven analytics, which aligns with Ipsoss investment in its digital platform and data science capabilities.
- Organic revenue growth driven by AI and data analytics demand
- Margin pressure from rising operational costs in mature European markets
- Currency headwinds from emerging market exposure in EMEA and APAC
- Competition intensifies from Nielsen and GfK in consumer research
- Capital allocation focused on debt reduction following SE Asia acquisition
| Net Income: 174.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 0.35 > 1.0 |
| NWC/Revenue: 12.34% < 20% (prev 13.79%; Δ -1.45% < -1%) |
| CFO/TA 0.10 > 3% & CFO 298.4m > Net Income 174.3m |
| Net Debt (481.9m) to EBITDA (403.0m): 1.20 < 3 |
| Current Ratio: 1.44 > 1.5 & < 3 |
| Outstanding Shares: last quarter (43.0m) vs 12m ago -3.20% < -2% |
| Gross Margin: 22.39% > 18% (prev 68.76%; Δ -46.37% > 0.5%) |
| Asset Turnover: 86.94% > 50% (prev 66.01%; Δ 20.93% > 0%) |
| Interest Coverage Ratio: 9.89 > 6 (EBIT TTM 298.4m / Interest Expense TTM 30.2m) |
| A: 0.10 (Total Current Assets 1.03b - Total Current Liabilities 719.5m) / Total Assets 2.99b |
| B: 0.01 (Retained Earnings 40.9m / Total Assets 2.99b) |
| C: 0.10 (EBIT TTM 298.4m / Avg Total Assets 2.92b) |
| D: 1.05 (Book Value of Equity 1.53b / Total Liabilities 1.46b) |
| Altman-Z'' = 2.52 = A |
| DSRI: 0.89 (Receivables 686.3m/568.5m, Revenue 2.54b/1.88b) |
| GMI: 3.07 (GM 68.76% / 22.39%) |
| AQI: 0.98 (AQ_t 0.61 / AQ_t-1 0.62) |
| SGI: 1.35 (Revenue 2.54b / 1.88b) |
| TATA: -0.04 (NI 174.3m - CFO 298.4m) / TA 2.99b) |
| Beneish M = -1.00 (Cap -4..+1) = D |
As of October 15, 2026, the stock is trading at EUR 35.78 with a total of 113,316 shares traded. Over the past week, the price has changed by -0.78%, over one month by -0.83%, over three months by +1.19% and over the past year by +8.77%.
Current recommended Stop Loss: 34.70 (which is 3% or 1.3 ATR below the current price).
Ipsos has no consensus analysts rating.
P/E Trailing = 8.9626
P/E Forward = 6.0168
P/S = 0.5868
P/B = 0.9515
P/EG = 1.4433
Revenue TTM = 2.54b EUR
EBIT TTM = 298.4m EUR
EBITDA TTM = 403.0m EUR
Long Term Debt = 486.5m EUR (from longTermDebt, last quarter)
Short Term Debt = 55.9m EUR (from shortTermDebt, last quarter)
Debt = 772.3m EUR (from shortLongTermDebtTotal, last quarter) + Leases 131.2m
Net Debt = 481.9m EUR (calculated: Debt 772.3m - CCE 290.3m)
Enterprise Value = 1.97b EUR (1.49b + Debt 772.3m - CCE 290.3m)
Interest Coverage Ratio = 9.89 (Ebit TTM 298.4m / Interest Expense TTM 30.2m)
EV/FCF = 9.20x (Enterprise Value 1.97b / FCF TTM 214.3m)
FCF Yield = 10.86% (FCF TTM 214.3m / Enterprise Value 1.97b)
FCF Margin = 8.44% (FCF TTM 214.3m / Revenue TTM 2.54b)
Net Margin = 6.86% (Net Income TTM 174.3m / Revenue TTM 2.54b)
Gross Margin = 22.39% ((Revenue TTM 2.54b - Cost of Revenue TTM 1.97b) / Revenue TTM)
Gross Margin QoQ = 18.84% (prev 25.42%)
Tobins Q-Ratio = 0.66 (Enterprise Value 1.97b / Total Assets 2.99b)
Interest Expense / Debt = 3.91% (Interest Expense 30.2m / Debt 772.3m)
Taxrate = 25.88% (61.5m / 237.8m)
NOPAT = 221.2m (EBIT 298.4m * (1 - 25.88%))
Current Ratio = 1.44 (Total Current Assets 1.03b / Total Current Liabilities 719.5m)
Debt / Equity = 0.50 (Debt 772.3m / totalStockholderEquity, last quarter 1.53b)
Debt / EBITDA = 1.20 (Net Debt 481.9m / EBITDA 403.0m)
Debt / FCF = 2.25 (Net Debt 481.9m / FCF TTM 214.3m)
Total Stockholder Equity = 1.53b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.97% (Net Income 174.3m / Total Assets 2.99b)
RoE = 11.42% (Net Income TTM 174.3m / Total Stockholder Equity 1.53b)
RoCE = 14.83% (EBIT 298.4m / Capital Employed (Equity 1.53b + L.T.Debt 486.5m))
RoIC = 10.04% (NOPAT 221.2m / Invested Capital 2.20b)
WACC = 5.35% (E(1.49b)/V(2.26b) * Re(6.62%) + D(772.3m)/V(2.26b) * Rd(3.91%) * (1-Tc(0.26)))
Discount Rate = 6.62% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -97.16 | Cagr: -2.67%
[DCF] Terminal Value 76.72% ; FCFF base≈206.1m ; Y1≈225.0m ; Y5≈281.5m
[DCF] Fair Price = 92.21 (EV 4.31b - Net Debt 481.9m = Equity 3.82b / Shares 41.5m; r=8.35% [WACC [floored]]; 5y FCF grow 10.52% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.0 | # QB: 0
Revenue Correlation: -26.08 | Revenue CAGR: -3.56% | SUE: N/A | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS current Year (2026-12-31): EPS=5.20 | Chg30d=-0.50% | Revisions=-40% | GrowthEPS=-5.5% | GrowthRev=+1.3%
EPS next Year (2027-12-31): EPS=5.63 | Chg30d=-0.48% | Revisions=-40% | GrowthEPS=+8.4% | GrowthRev=+2.9%
[Analyst] Revisions Ratio: -57% (up=0, down=4)